Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
Tags: health-medicine coronavirus covid-19 dan-h-barouch harvard-medical-school ragon-institute re-infection sars-cov-2 vaccine
An outpouring of volunteers and equipment from the Harvard medical community have helped a Harvard hospital testing lab meet COVID’s challenge.
Tags: health-medicine alvin-powell annie-cheng beth-israel-deaconess-medical-center covid-19 erin-duffy james-kirby jeffrey-saffitz jihoon-lim laboratory-technician molecular-diagnostics-lab pathology sars-cov-2 testing volunteer
Harvard researchers are turning to two common cold viruses to learn lessons about how the coronavirus that causes COVID-19 might behave in the coming months.
Tags: health-medicine cold-virus covid-19 pandemic sars-cov-2
Further research and development on a class of molecules called bisphosphonates might turbocharge a vaccine against SARS-CoV-2, the novel coronavirus, and help bring immunity to huge populations more quickly.
Tags: science-technology basic-research covid-19 harvard-office-of-technology-development mit-and-harvard ragon-institute-of-mgh sars-cov-2 uli-von-andrian
The newly formed Massachusetts Consortium on Pathogen Readiness aims to address both the immediate and long-term implications of the coronavirus crisis. The effort, led by Harvard Medical School, will work to stem the tide of COVID-19 but, more importantly, to lay the groundwork for dealing with future pandemics.
Tags: health-medicine basic-research blavatnik-institute coronavirus covid-19 harvard-medical-school sars-cov-2-pandemic
Harvard’s Global Health Institute puts its research expertise into motion, helping hospitals assess capacity and quality of care so they can prepare for COVID-19 patients appropriately.
Tags: health-medicine ashish-jha basic-research coronavirus covid-19 data-science harvard-global-health-institute hospital-referral-regions immunology italy mary-todd-bergman propublica sars-cov-2
Page 1 of 1